Paris-based medical imaging company EOS imaging announced today that its spineEOS software—an online 3D tool for spine surgery planning—has received FDA approval.
The software allows surgeons to create treatment strategies from pelvic and vertebral 3D data resulting from an EOS exam, which can in turn be used to formulate a plan based on the exact shape and length of the spinal implants.
“We believe that patients’ spines are complex 3D systems that need a personalized 3D planning of the intended surgery,” said ESO imaging CEO, Marie Meynadier, in a press release. “We look forward to this next important step toward our broader goal of expanding our EOSapps planning software suite to better connect imaging to patient care.”
Approval of the software allows the company to continue its expansion into the growing U.S. spine market, which includes approximately 400,000 patients per year at an orthopedic implant value of $3 billion.